This report was in our paper in the uk. Is this something new to you all or am I giving you old news. The trial involved1651 people with SPMS this drug was shown to reduce the risk of disability by 21%. It also significantly reduced the rate of brain shrinkage and the number of relapses people experienced. If you want to know more I would be happy to let you know, but again I don't want to be telling you what you already know, we appear to be alittle behind in the uk. God bless Jimeka
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.